Sara Robinson1, Amr Soliman1, Mehdi Karkouri2, Hoda Gad Omer3, Joel F Greenson4. 1. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA. 2. Department of Pathology, Mohammed V University, Casablanca, Morocco. 3. Department of Pathology, Tanta Cancer Center, Tanta, Egypt. 4. Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Abstract
INTRODUCTION: Pancreatic cancer has not been well studied, especially in developing countries. MATERIALS AND METHODS: We studied the variations in genetic mutations in pancreatic adenocarcinoma between Moroccan and Egyptian populations. The molecular pathology of 30 tumors from a large hospital in Casablanca, Morocco were examined and compared with the findings of 44 tumors from the Gharbiah Governate in Egypt. K-ras mutations in codons12 and 13 in addition to p53 mutations in exons 5-8 were evaluated. RESULTS: Overall, differences in the rates of K-ras mutations were not statistically significant (48.00 and 34.09%, respectively); however differences in rates of p53 mutations were statistically significant with p53 mutations more common in Moroccan tumors than in Egyptian tumors (46.67 and 16.28%, respectively). GT mutations of the K-ras gene were most commonly seen Egyptian tumors, whereas G → A mutations were the most common type of mutations in Moroccan tumors. Logistic regression analysis showed that a p53 mutation in any exon as well as a p53 mutation in exon 5 predicted the country of residence and those mutations occurred more frequently in Moroccan patients. CONCLUSION: Our study shows that differences exist within the Arab population in the molecular pathology of both the K-ras and p53 genes. Further studies are necessary to clarify the differences in molecular pathways of pancreatic cancer in the Middle East and to investigate the role of environmental and/or genetic factors related to those pathways.
INTRODUCTION:Pancreatic cancer has not been well studied, especially in developing countries. MATERIALS AND METHODS: We studied the variations in genetic mutations in pancreatic adenocarcinoma between Moroccan and Egyptian populations. The molecular pathology of 30 tumors from a large hospital in Casablanca, Morocco were examined and compared with the findings of 44 tumors from the Gharbiah Governate in Egypt. K-ras mutations in codons12 and 13 in addition to p53 mutations in exons 5-8 were evaluated. RESULTS: Overall, differences in the rates of K-ras mutations were not statistically significant (48.00 and 34.09%, respectively); however differences in rates of p53 mutations were statistically significant with p53 mutations more common in Moroccan tumors than in Egyptian tumors (46.67 and 16.28%, respectively). GT mutations of the K-ras gene were most commonly seen Egyptian tumors, whereas G → A mutations were the most common type of mutations in Moroccan tumors. Logistic regression analysis showed that a p53 mutation in any exon as well as a p53 mutation in exon 5 predicted the country of residence and those mutations occurred more frequently in Moroccan patients. CONCLUSION: Our study shows that differences exist within the Arab population in the molecular pathology of both the K-ras and p53 genes. Further studies are necessary to clarify the differences in molecular pathways of pancreatic cancer in the Middle East and to investigate the role of environmental and/or genetic factors related to those pathways.
Authors: C H Chung; R E Wilentz; M M Polak; T B Ramsoekh; L A Noorduyn; D J Gouma; K Huibregtse; G J Offerhaus; R J Slebos Journal: J Clin Pathol Date: 1996-06 Impact factor: 3.411
Authors: Amr S Soliman; Melissa Bondy; Charity Renee Webb; David Schottenfeld; Joseph Bonner; Nabih El-Ghawalby; Ahmed Soultan; Mohamed Abdel-Wahab; Omar Fathy; Gamal Ebidi; Qing Zhang; Joel K Greenson; James L Abbruzzese; Stanley R Hamilton Journal: Int J Cancer Date: 2006-09-15 Impact factor: 7.396
Authors: Amr S Soliman; An-Chi Lo; Mousumi Banerjee; Nabih El-Ghawalby; Hussein M Khaled; Sherif Bayoumi; Ibrahim A Seifeldin; Atef Abdel-Aziz; James L Abbruzzese; Joel K Greenson; Stanley R Hamilton Journal: Carcinogenesis Date: 2007-06-16 Impact factor: 4.944
Authors: Alison M Kriegel; Amr S Soliman; Qing Zhang; Nabih El-Ghawalby; Farouk Ezzat; Ahmed Soultan; Mohamed Abdel-Wahab; Omar Fathy; Gamal Ebidi; Nadia Bassiouni; Stanley R Hamilton; James L Abbruzzese; Michelle R Lacey; Diane A Blake Journal: Environ Health Perspect Date: 2006-01 Impact factor: 9.031
Authors: Brittney L Smith; Mohamed Ramadan; Brittany Corley; Ahmed Hablas; Ibrahim A Seifeldein; Amr S Soliman Journal: Cancer Epidemiol Date: 2015-11-18 Impact factor: 2.984